A new report projects the average cost of employer-sponsored health plans to rise 9 percent next year. The Centers for Medicare and Medicaid Services receives 12,000-plus complaints about No Surprises noncompliance. And, the FDA approves a chemo-free treatment for a common type of lung cancer. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.